← Back to headlines
Eli Lilly's Foundayo and Zepbound Available to Medicare Part D Enrollees
Eli Lilly announced that its drugs Foundayo and Zepbound will be accessible to Medicare Part D beneficiaries starting July 1.
25 Jun, 13:05 — 25 Jun, 13:05
Sources
Showing 1 of 1 sources
